Employee Benefit and Deferred Compensation Plans - Summary of the Changes in Restricted Stock (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Performance shares
Performance-Based Restricted Stock
Nonvested at beginning of period (in shares) | shares	169,575
Awarded (in shares) | shares	95,048
Vested (in shares) | shares	0
Cancelled (in shares) | shares	0
Nonvested at end of period (in shares) | shares	264,623
Weighted Average Grant-Date Fair Value
Nonvested at beginning balance (in usd per share) | $ / shares	$ 36.38
Awarded (in usd per share) | $ / shares	33.44
Vested (in usd per share) | $ / shares	0
Cancelled (in usd per share) | $ / shares	0
Nonvested at end balance (in usd per share) | $ / shares	$ 35.32
Restricted stock
Performance-Based Restricted Stock
Nonvested at beginning of period (in shares) | shares	779,564
Awarded (in shares) | shares	312,940
Vested (in shares) | shares	(219,951)
Cancelled (in shares) | shares	(3,599)
Nonvested at end of period (in shares) | shares	868,954
Weighted Average Grant-Date Fair Value
Nonvested at beginning balance (in usd per share) | $ / shares	$ 36.20
Awarded (in usd per share) | $ / shares	33.19
Vested (in usd per share) | $ / shares	36.33
Cancelled (in usd per share) | $ / shares	34.04
Nonvested at end balance (in usd per share) | $ / shares	$ 35.10